The nation's leading healthcare performance improvement company

Our Difference Defined

We call it The Vizient Difference. Learn more.
Download now
Expert report
If you refer them, they will come
Introducing Provider Connections. Learn about our newest analytic tool.
Blog
Three Years In – and the End of the PHE Declaration is in Sight
After three years of the COVID-19 Public Health Emergency determination, Emily Jones outlines what healthcare providers need to know about deadlines, flexibilities, and the path ahead.
Blog
Biosimilars are The Same, Yet Different, and That May Impact Utilization
Come Jan. 31, Humira (adalimumab) will lose its exclusivity, opening the door for the eight approved biosimilars to come to market.
Story
DEI: It’s Hard Work, but Important Work. And Vizient is Up for the Challenge.
It's a phrase Chief Culture, Diversity and Inclusion Officer Monica Davy says often.

We solve healthcare challenges for
academic medical centers
community hospitals
integrated delivery networks
non-acute care providers
pediatric facilities

Talk to our team of experts
What can we do for you?Talk to our team of experts

Savings and value in the new era of biosimilars

Biosimilars have proven to be clinically effective while providing significant cost savings. Vizient has insights and solutions to help design and support your biosimilar strategy and adoption.

What we do

Latest insights

Our Impact

Rush University Medical CenterCase studyData spurs a new spend management approach for shoulder replacement surgery at Rush UMC

Reimagining care delivery to empower your healthcare workforce

Healthcare workforce solutions designed for the heart of your operation, your teams.

What we do

Latest insights

Our Impact

UCLA SepsisCase studyLeveraging insights to improve sepsis care

More than a payment model

Value-based care success starts with an organization’s ability to provide consistent, high-quality care across the continuum.

What we do

Latest insights

Our Impact

Executive summary: Pandemic recovery timing and health care projectionsExecutive summaryPandemic recovery timing and health care projections

Vizient is trusted by over 50% of U.S. health care organizations

  • 97%

    of academic medical centers

  • >60%

    of acute care hospitals in the U.S.

  • >20%

    of the ambulatory market in the U.S.

Speak with our team of experts to learn more

Send a message

Share your contact details and we’ll get back to you

Call our team

Speak directly with our experts